ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,679 | +743.7% | 81,947 | +605.7% | 0.02% | +850.0% |
Q1 2023 | $199 | -1.0% | 11,612 | +13.0% | 0.00% | 0.0% |
Q4 2022 | $201 | -100.0% | 10,272 | -68.3% | 0.00% | -66.7% |
Q3 2022 | $517,000 | -23.7% | 32,366 | -34.3% | 0.01% | -14.3% |
Q2 2022 | $678,000 | -61.0% | 49,242 | -38.2% | 0.01% | -22.2% |
Q4 2021 | $1,738,000 | +179.0% | 79,622 | +281.9% | 0.01% | +200.0% |
Q3 2021 | $623,000 | +275.3% | 20,847 | +455.0% | 0.00% | +200.0% |
Q2 2021 | $166,000 | -60.8% | 3,756 | -60.6% | 0.00% | -50.0% |
Q1 2021 | $423,000 | +13.1% | 9,533 | +39.9% | 0.00% | 0.0% |
Q4 2020 | $374,000 | +87.9% | 6,814 | -21.7% | 0.00% | +100.0% |
Q3 2020 | $199,000 | +11.2% | 8,701 | +1.5% | 0.00% | 0.0% |
Q2 2020 | $179,000 | – | 8,570 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |